Outcomes of buprenorphine maintenance in office-based practice

被引:28
|
作者
Magura, Stephen
Lee, Stephen J.
Salsitz, Edwin A.
Kolodny, Andrew
Whitley, Susan D.
Taubes, Tanaquil
Seewald, Randy
Joseph, Herman
Kayman, Deborah J.
Fong, Chunki
Marsch, Lisa A.
Rosenblum, Andrew
机构
[1] Natl Dev & Res Inst Inc, New York, NY 10010 USA
[2] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[3] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
关键词
buprenorphine; opioids; substance misuse; office-based treatment; drug dependence treatment; OPIOID DEPENDENCE; PSYCHIATRIC-DIAGNOSIS; HEROIN DEPENDENCE; CONTROLLED TRIAL; OPIATE ADDICTS; METHADONE; COMORBIDITY; ABUSE;
D O I
10.1300/J069v26n02_03
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Buprenorphine is an efficacious treatment for opioid dependence recently approved for office-based medical practice. The purpose of the study was to describe the background characteristics, treatment process, outcomes and correlates of outcomes for patients receiving buprenorphine maintenance in "real world" office-based settings in New York City, without employing the many patient exclusion criteria characterizing clinical research studies of buprenorphine, including absence of co-occurring psychiatric and non-opioid substance use disorders. A convenience sample of six physicians completed anonymous chart abstraction forms for all patients who began buprenorphine induction or who transferred to these practices during 2003-2005 (N = 86). The endpoint was the patient's current status or status at discharge from the index practice, presented in an intent-to-treat analysis. The results were: male (74%); median age (38 yrs); White, non-Hispanic (82%); employed full-time, (58%); HCV+ (15%); substance use at intake: prescription opioids (50%), heroin (35%), non-opioids (49%); median length of treatment (8 months); median maintenance dose (15 mg/day); prescribed psychiatric medication (63%). The most frequent psychiatric disorders were: major depression, obsessive-compulsive and other anxiety, bipolar. At the endpoint: retained in the index practice (55%); transferred to other buprenorphine practice (6%); transferred to other treatment (7%); lost to contact or out of any treatment (32%). Outcomes were positive, in that 2/3 of patients remained in the index practice or transferred to other treatment. Patients living in their own home or misusing prescription opioids (rather than heroin) were more likely, and those employed part-time were less likely, to be retained in the index practice. At the endpoint, 24% of patients were misusing drugs or alcohol. Co-occurring psychiatric disorders and polysubstance abuse at intake were common, but received clinical attention, which may explain why their effect on outcomes was minimal.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
  • [1] Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy
    Parran, T. V.
    Adelman, C. A.
    Merkin, B.
    Pagano, M. E.
    Defranco, R.
    Ionescu, R. A.
    Mace, A. G.
    DRUG AND ALCOHOL DEPENDENCE, 2010, 106 (01) : 56 - 60
  • [2] CRIMINAL CHARGES AND OUTCOMES OF PATIENTS ENTERING OFFICE-BASED BUPRENORPHINE MAINTENANCE THERAPY
    Harris, Elizabeth Edith
    Jacapraro, Janet
    Jasinski, Donald
    Rastegar, Darius
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S35 - S35
  • [3] Buprenorphine for office-based practice: Consensus conference overview
    Kosten, TR
    Fiellin, DA
    AMERICAN JOURNAL ON ADDICTIONS, 2004, 13 : S1 - S7
  • [4] Prior Buprenorphine Experience Is Associated With Office-Based Buprenorphine Treatment Outcomes
    Cunningham, Chinazo O.
    Roose, Robert J.
    Starrels, Joanna L.
    Giovanniello, Angela
    Sohler, Nancy L.
    JOURNAL OF ADDICTION MEDICINE, 2013, 7 (04) : 287 - 293
  • [5] PRIOR BUPRENORPHINE EXPERIENCE IS ASSOCIATED WITH OFFICE-BASED BUPRENORPHINE TREATMENT OUTCOMES
    Cunningham, Chinazo
    Roose, Robert
    Starrels, Joanna L.
    Giovanniello, Angela G.
    Sohler, Nancy
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S288 - S288
  • [6] Buprenorphine maintenance: Office-based treatment with addiction clinic support
    Ortner, R
    Jagsch, R
    Schindler, SD
    Primorac, A
    Fischer, G
    EUROPEAN ADDICTION RESEARCH, 2004, 10 (03) : 105 - 111
  • [7] Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
    Barry, Declan T.
    Irwin, Kevin S.
    Jones, Emlyn S.
    Becker, William C.
    Tetrault, Jeanette M.
    Sullivan, Lynn E.
    Hansen, Helena
    O'Connor, Patrick G.
    Schottenfeld, Richard S.
    Fiellin, David A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (02) : 218 - 225
  • [8] Buprenorphine Program Evaluation in a Private Psychiatric Office-Based Practice
    Palmer, Joshua
    Mitchell, Ann M.
    Schlenk, Elizabeth A.
    Mullick, Prabir
    Lee, Heeyoung
    JOURNAL OF ADDICTIONS NURSING, 2023, 34 (01) : 89 - 95
  • [9] Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
    Declan T. Barry
    Kevin S. Irwin
    Emlyn S. Jones
    William C. Becker
    Jeanette M. Tetrault
    Lynn E. Sullivan
    Helena Hansen
    Patrick G. O’Connor
    Richard S. Schottenfeld
    David A. Fiellin
    Journal of General Internal Medicine, 2009, 24 : 218 - 225
  • [10] Pain Is Not Associated with Worse Office-Based Buprenorphine Treatment Outcomes
    Fox, Aaron D.
    Sohler, Nancy L.
    Starrels, Joanna L.
    Ning, Yuming
    Giovanniello, Angela
    Cunningham, Chinazo O.
    SUBSTANCE ABUSE, 2012, 33 (04) : 361 - 365